GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 3 39-3, 1999, Pages

  Defalque, Dominique ^a   Brandt, Nathalie ^a   Ketelslegers, Jean Marie ^a   Thissen, Jean Paul ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Gene expression; Growth hormone resistance; Insulin like growth factor I

Indexed keywords

ENDOTOXIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIVER METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RECEPTOR DENSITY; SEPSIS;

EID: 0032945579     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.3.e565     Document Type: Article

References (35)

1. Baumbach, W. R., D. Horner, J. S. Logan. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev. 3: 1199-1205, 1989.
2. Baxter, R. C. Measurement of growth hormone and prolactin receptor turnover in rat liver. Endocrinology 117: 650-655, 1985.
3. Beauloye, V., J.-M. Ketelslegers, and J.-P. Thissen. The inhibition of growth hormone (GH)-induction of insulin-like growth factor (IGF)-I mRNA by dexamethasone is associated with diminished growth hormone receptor mRNA levels in rat primary cultured hepatocytes (Abstract). Proc. Int. Cong. Endocrinol. 10th San Francisco, CA 1996, p. 431.
4. Casella, S. J., B. P. Smith, J. J. Van Wyk, D. R. Joseph, M. A. Hynes, E. D. Hoyt, and P. K. Lund. Isolation of rat testis cDNAs encoding an insulin-like growth factor I precursor. DNA 6: 325-330, 1987.
5. Copeland, K. C., L. E. Underwood, and J. J. Van Wyk. Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on Chromatographic profiles. J. Clin. Endocrinol. Metab. 50: 690-697, 1980.
6. Dahn, M. S., M. P. Lange, and L. A. Jacobs. Insulin-like growth factor-I production is inhibited in human sepsis. Arch. Surg. 123: 1409-1414, 1988.
7. Davenport, M. L., M. E. Svoboda, K. L. Koerber, J. J. Van Wyk, D. R. Clemmons, and L. E. Underwood. Serum concen trations of insulin-like growth factor II are not changed by short-term fasting and refeeding. J. Clin. Endocrinol. Metab. 67: 1231-1236, 1988.
8. Donaghy, A. J., and R. C. Baxter. Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. Baillieres Clin. Endocrinol. Metab. 10: 421-446, 1996.
9. Fan, J., D. Char, G. J. Bagby, M. C. Gelato, and C. H. Lang. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R1204-R1212, 1995.
10. Fan, J., P. E. Molina, M. C. Gelato, and C. H. Lang. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134: 1685-1692, 1994.
11. Fan, J., M. Wojnar, M. Theodorakis, and C. H. Lang. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R621-R629, 1996.
12. Frick, G. P., L. R. Tai, W. R. Baumbach, and H. M. Goodman. Tissue distribution, turnover, and glycosylation of the long and short growth hormone receptor isoforms in rat tissues. Endocrinology 139: 2824-2830, 1998.
13. Kelly, P. A., G. Leblanc, and J. Djiane. Estimation of total prolactin binding sites after in vitro desaturation. Endocrinology 104: 1631-1638, 1979.
14. King, A. P., and C. Carter-Su. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts. Endocrinology 136: 4796-4803, 1995.
15. Lang, C. H., J. Fan, R. Cooney, and T. C. Vary. IL-1 receptor antagonist attenuates sepsis-induced alteration in the IGF system and protein synthesis. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E430-E437, 1996.
16. Liao, W., M. Rudling, and B. Angelin. Contrasting effects of growth hormone and insulin-like growth factor I on the biological activities of endotoxin in the rat. Endocrinology 138: 289-295, 1997.
17. Lund, P. K., E. C. Hoyt, and J. J. Van Wyk. The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3′-untranslated sequence. Mol. Endocrinol. 3: 2054-2061, 1989.
18. Luo, J., and L. J. Murphy. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 125: 165-171, 1989.
19. Maes, M., J.-M. Ketelslegers, and L. E. Underwood. Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus: correlation with changes in somatogenic and lactogenic liver binding sites. Diabetes 32: 1060-1069, 1983.
20. Maes, M., L. E. Underwood, and J.-M. Ketelslegers. Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites. J. Endocrinol. 97: 243-252, 1983.
21. Maes, M., L. E. Underwood, and J.-M. Ketelslegers. Low serum somatomedin-C in protein deficiency: relationship with changes in liver somatogenic and lactogenic binding sites. Mol. Cell. Endocrinol. 37: 301-309, 1984.
22. Maiter, D., M. Maes, L. E. Underwood, T. Fliesen, G. Gerard, and J.-M. Ketelslegers. Early changes in serum concentrations of somatomedin-C induced by dietary protein deprivation in rats: contributions of growth hormone receptor and post-receptor defects. J. Endocrinol. 118: 113-120, 1988.
23. Massa, G., N. Mulumba, J.-M. Ketelslegers, and M. Maes. Initial characterization and sexual dimorphism of serum growth hormone-binding protein in adult rats. Endocrinology 126: 1976-1980, 1990.
24. Mathews, L. S., B. Enberg, and G. Norstedt. Regulation of rat growth hormone receptor gene expression. J. Biol. Chem. 264: 9905-9910, 1989.
25. Peisen, J. N., K. J. McDonnell, S. E. Mulroney, and M. D. Lumpkin. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1β and corticotropin-releasing factor in the juvenile rat. Endocrinology 136: 3378-3390, 1995.
26. Ross, R., J. Miell, E. Freeman, J. Jones, D. Matthews, M. Prece, and C. Buchanan. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin. Endocrinol. (Oxf.) 35: 47-54, 1991.
27. Roth, E., L. Valentini, M. Semsroth, T. Holzenbein, S. Winkler, W. F. Blum, M. B. Ranke, M. Schemper, A. Hammerle, and J. Karner. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J. Trauma 38: 136-141, 1995.
28. Russell-Jones, D. L., A. M. Umpleby, T. R. Hennessy, S. B. Bowes, F. Shojaee Moradie, K. D. Hopkins, N. C. Jackson, J. M. Nelly, R. H. Jones, and P. H. Sonksen. Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E591-E598, 1994.
29. Sakurai, Y., X. J. Zhang, and R. R. Wolfe. Insulin-like growth factor-I and insulin reduced leucine flux and oxidation in conscious tumor necrosis factor-infused dogs. Surgery 117: 305-313, 1995.
30. Tannenbaum, G. S., O. Rorstad, and P. Brazeau. Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology 104: 1733-1738, 1979.
31. Thissen, J. P., J.-M. Ketelslegers, and L. E. Underwood. Nutritional regulation of insulin-like growth factors. Endocr. Rev. 15: 80-101, 1994.
32. Thissen, J. P., S. Triest, B. M. Moats-Staats, L. E. Underwood, T. Mauerhoff, D. Maiter, and J.-M. Ketelslegers. Evidence that pretranslational and translational defects decrease serum insulin-like growth factor-I concentrations during dietary protein restriction. Endocrinology 129: 429-435, 1991.
33. Thissen, J. P., and J. Verniers. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078-1084, 1997.
34. Wojnar, M. M., J. Fan, R. A. Frost, M. C. Gelato, and C. H. Lang. Alterations in the insulin-like growth factor system in trauma patients. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R970-R977, 1995.
35. Wolfe, R. R. Herman Award Lecture, 1996: relation of metabolic studies to clinical nutrition - the example of burn injury. Am. J. Clin. Nutr. 64: 800-808, 1996.